CHRM1 and fibrosis: Bile duct hyperplasia in AOM-treated WT mice was reduced with M1R deficiency (Fig. 4E,F); bile duct hyperplasia correlated positively with hepatic fibrosis (Pearson r2 = 0.734; p < 0.001).